(Press-News.org) ATS 2012, SAN FRANCISCO – There is a very high prevalence of osteopenia/osteoporosis among male patients with pulmonary disease, according to a new study from researchers in California.
"While post-menopausal women are routinely screened for osteoporosis, men are not," said Kathleen Ellstrom, PhD, RN, APRN-BC, Pulmonary Clinical Nurse Specialist and Director of the Pulmonary Rehabilitation Program at the Veterans Administration Loma Linda Healthcare System. "The high prevalence of bone disease we found in male patients referred to our pulmonary rehabilitation program suggests that routine screening should also be performed in men with pulmonary disease."
The results will be presented at the ATS 2012 International Conference in San Francisco.
The study included 46 patients, 43 of whom underwent dual-emission X-ray absorptiometry (DXA) screening. The majority (98%) of patients were male. Diagnoses included chronic obstructive pulmonary disease (COPD, 80%), idiopathic pulmonary fibrosis (IPF, 16%), and asthma (4%).
Of the 43 patients who underwent DXA scanning, 27 (63%) had positive scans. Of these 27 patients, 21 (78%) had osteopenia and 6 (22%) had osteoporosis. The severity of lung disease was also associated with bone disease as those patients with more severe lung disease were more likely to also have bone disease.
"Smoking and the use of steroids to treat exacerbations in patients with lung disease are factors known to be associated with an increased risk of osteopenia/osteoporosis. In addition, recent evidence suggests that COPD itself may be associated with an increased risk secondary to an inflammatory process independent of steroid use," said Dr. Ellstrom.
"Our findings suggest that routine screening for osteopenia/osteoporosis in male patients with pulmonary disease may help reduce the occurrence of fractures in these patients by identifying at-risk individuals that might otherwise not be evaluated and treated."
###
"High Prevalence Of Osteopenia/Osteoporosis In Patients Referred For Pulmonary Rehabilitation" (Session A107, Sunday, May 20, 2:00- 4:30 p.m., Room 3010-3012, Moscone Center; Abstract 32409)
* Please note that numbers in this release may differ slightly from those in the abstract. Many of these investigations are ongoing; the release represents the most up-to-date data available at press time.
Abstract 32409
High Prevalence Of Osteopenia/Osteoporosis In Patients Referred For Pulmonary Rehabilitation
Type: Scientific Abstract
Category: 15.06 - Pulmonary Rehabilitation: Patient Assessment (PR)
Authors: K. Ellstrom, N.L. Specht; VA Loma Linda Healthcare System - Loma Linda, CA/US
Abstract Body
INTRODUCTION: Recent studies implicate Chronic Obstructive Pulmonary Disease (COPD) in the development of osteopenia/osteoporosis secondary to an inflammatory process independent of steroid use. Additionally, the use of steroids for exacerbations in lung disease place patients at increased risk. Women are routinely screened for osteoporosis post-menopause, whereas men are not. We initiated Dual-emission X-ray Absorptiometry (DXA) screening for all patients referred to our pulmonary rehabilitation program in an attempt to assess bone density and intervene early if results were abnormal.
METHODS: As part of the routine intake into the pulmonary rehabilitation program for the past two years, patients were assessed to see if DXA scans had been done previously. If not, patients were sent for a DXA scan. If the results were abnormal, medications were prescribed: alendronate 70 mg weekly, calcium 500 mg and vitamin D 2000u daily.
This data has been collated and analyzed to assess the incidence of osteopenia/osteoporosis in our Veterans Administration pulmonary rehabilitation patient population.
RESULTS: Forty-three of 46 patients completed the DXA scan. Ages ranged from 47-91 years (mean 68.9); 98% were male; ethnicities were 72% White, 17% Black, and 11% Hispanic/Latino. Diagnosis was COPD (80%), 16% Idiopathic Pulmonary Fibrosis (IPF) and 4% Asthma. Post-bronchodilator FEV1 ranged from 12% to 83% of predicted, with the higher ones mostly in the IPF patients; 33% were GOLD Stage II, 48% were Stage III, and 19% had Stage IV disease. Fifty-nine percent had a high C-reactive protein level.
Of the 43 patients who completed the scan, 63% (n=27) had a positive DXA scan. Of those, 78% (n=21) had osteopenia and 22% (n=6) showed osteoporosis.
CONCLUSIONS: Male veterans with pulmonary disease are at risk for bone disease. The prevalence of osteopenia/osteoporosis is very high in this population and routine screening may help to reduce fractures.
Funded by: None reported
High prevalence of bone disease in patients referred for pulmonary rehabilitation
2012-05-21
ELSE PRESS RELEASES FROM THIS DATE:
Risk factors for an exacerbation-prone asthma phenotype
2012-05-21
ATS 2012, SAN FRANCISCO – A number of specific risk factors are associated with an exacerbation-prone phenotype of severe asthma, according to a new study from researchers in Sweden.
The results will be presented at the ATS 2012 International Conference in San Francisco.
"Acute exacerbations are a major source of morbidity and mortality in asthma," said lead author Maciek Kupczyk, MD, PhD, a researcher at the Karolinska Institutet in Stockholm "In children, the costs of asthma care are three times higher in exacerbators as compared to those patients who did not experience ...
Study says children exposed to tobacco smoke face long-term respiratory problems
2012-05-21
ATS 2012, SAN FRANCISCO – For more than three decades, researchers have warned of the potential health risks associated with exposure to environmental tobacco smoke (ETS), especially among children whose parents smoke. Now a new study conducted by researchers from the University of Arizona reports that those health risks persist well beyond childhood, independent of whether or not those individuals end up becoming smokers later in life.
The study will be presented at the ATS 2012 International Conference in San Francisco.
"This study shows that exposure to parental ...
Treatment of childhood OSA reverses brain abnormalities
2012-05-21
ATS 2012, SAN FRANCISCO - Treatment of obstructive sleep apnea (OSA) in children normalizes disturbances in the neuronal network responsible for attention and executive function, according to a new study.
"OSA is known to be associated with deficits in attention, cognition, and executive function," said lead author Ann Halbower, MD, Associate Professor at the Children's Hospital Sleep Center and University of Colorado Denver. "Our study is the first to show that treatment of OSA in children can reverse neuronal brain injury, correlated with improvements in attention ...
Prenatal exposure to pollution especially dangerous for children with asthma
2012-05-21
ATS 2012, SAN FRANCISCO – The link between prenatal exposure to air pollution and childhood lung growth and respiratory ailments has been established by several studies in recent years, and now a new study suggests that these prenatal exposures can be especially serious for children with asthma.
The study will be presented at the ATS 2012 International Conference in San Francisco.
"In this study, we found that prenatal exposures to airborne particles and the pollutant nitrogen dioxide adversely affect pulmonary function growth among asthmatic children between 6 and ...
4 acute mushroom poisonings in 2 weeks
2012-05-21
SAN DIEGO – On September 12, 2011, a Springfield, Virginia man arrived at MedStar Georgetown University Hospital (MGUH) in the early stages of liver failure. The man had mistakenly eaten poisonous mushrooms, handpicked from his yard. He would be the first of four patients in the course of two weeks to seek treatment at MGUH for mushroom (amanitin) poisoning. Their clinical course, management, and outcomes were presented today at Digestive Disease Week (DDW) in San Diego, the largest international gathering of physicians and researchers in the field of gastroenterology, ...
Statins prevent cancer in heart transplant recipients
2012-05-21
Statins prevent cancer and reduce death from all causes in heart transplant recipients. The findings were independent of cholesterol levels.
The research was presented at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology.
Cancer is the leading cause of death late after heart transplantation. Skin cancer is particularly common, but solid organ cancers including colorectal cancer, prostate cancer and lymphoma also occur. The increased rate of ...
UW study: Sleep apnea associated with higher mortality from cancer
2012-05-21
Madison, Wis. and San Francisco — Sleep-disordered breathing (SDB), commonly known as sleep apnea, is associated with an increased risk of cancer mortality, according to a new study.
While previous studies have associated SDB with increased risks of hypertension, cardiovascular disease, depression, and early death, this is the first human study to link apnea with higher rate of cancer mortality. Lead author Dr. F. Javier Nieto, chair of the department of population health sciences at the UW School of Medicine and Public Health, says the study showed a nearly five times ...
First, do no harm: Study finds danger in standard treatment for a serious lung disease
2012-05-21
A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis, according to the surprising results of a rigorous independent study.
The study, which will appear online May 20 in the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American Thoracic Society, was conducted by IPF Clinical Research Network, funded by the National Heart, Lung, and Blood Institute ...
Lab tests show arthritis drug effective against global parasite
2012-05-21
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
Based on these results, the team has received Orphan Drug Status for the drug, known as auranofin, from the U.S. Food and Drug Administration, and has applied for approval to start clinical trials to treat both amebiasis and the parasite Giardia in humans.
The findings, which showed that ...
Drug found for parasite that is major cause of death worldwide
2012-05-21
Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against Entamoeba histolytica. This parasite causes amebic dysentery and liver abscesses and results in the death of more than 70,000 people worldwide each year.
Using a high-throughput screen for drugs developed by the research team, they discovered that auranofin – a drug approved by the US Food and Drug Administration 25 years ago for rheumatoid arthritis – is very effective ...